Coffee May Lower Risk of Liver Disease: Benefits & How It Works

Regular coffee consumption is linked to a reduced risk of several liver diseases, including fatty liver disease, cirrhosis, and liver cancer, according to a recent review of scientific literature. The findings, published in Biochemical Pharmacology, consolidate data from epidemiological, clinical, and experimental studies, detailing not only the protective effects of coffee but also the underlying mechanisms.

The review, which analyzed large meta-analyses and laboratory research, focused on key bioactive components of coffee – caffeine, chlorogenic acids, and diterpenes (including cafestol and kahweol). Researchers found that individuals who regularly drink coffee have a 29 percent lower risk of developing metabolically associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease. The same group exhibited approximately a 30 percent lower risk of liver fibrosis.

Meta-analyses suggest an even more significant reduction in risk, indicating up to a 40 percent lower risk of hepatocellular carcinoma (HCC), the most common type of liver cancer. The protective effect appeared more pronounced in individuals consuming at least three cups of coffee daily, suggesting a dose-response relationship. However, the study noted a weaker protective effect in patients with Hepatitis B, particularly those with high viral replication rates.

Clinical studies also demonstrated that regular coffee intake correlated with lower levels of liver enzymes (ALT, AST, GGT) – biomarkers indicative of liver cell damage. This suggests coffee may help mitigate ongoing liver injury.

The protective mechanisms of coffee are multifaceted. Researchers identified several key pathways. Coffee’s compounds activate the Nrf2 pathway, a protein regulating the body’s antioxidant response. This enhances the ability of cells to neutralize oxidative stress, a critical factor in liver damage. Coffee components limit the activity of factors responsible for initiating inflammatory responses, reducing the production of pro-inflammatory cytokines, potentially slowing the progression of chronic liver diseases.

Coffee also appears to inhibit liver fibrosis. Caffeine and other compounds within coffee hinder the activation of hepatic stellate cells, which are responsible for creating scar tissue. What we have is significant as chronic fibrosis can lead to cirrhosis. Studies suggest coffee can modulate fat and glucose metabolism, relevant to steatotic liver disease. Finally, coffee influences the gut microbiome, promoting the growth of beneficial bacteria like Bifidobacterium, and potentially reducing intestinal permeability, thereby limiting the influx of toxins to the liver.

The review emphasizes that the method of coffee preparation can influence its properties. Unfiltered coffee contains more diterpenes, which have biological activity but may also raise cholesterol levels. Filtration removes some of these compounds, potentially reducing lipid-related risks, but also potentially diminishing some protective effects.

While the epidemiological data is consistent, the authors caution that most studies are observational, preventing definitive conclusions about cause and effect. Further clinical trials are needed. Coffee should not be considered a treatment for liver diseases, but rather an element of a lifestyle that can support prevention. Potential adverse effects should also be considered.

Research from WebMD, published on March 8, 2024, corroborates these findings, noting that coffee drinkers may be less likely to develop fibrosis, cirrhosis, non-alcohol-related fatty liver disease, and even liver cancer. The article highlights that the benefits extend to both caffeinated and decaffeinated coffee, with one study suggesting decaf offers similar advantages.

The British Liver Trust also acknowledges the growing body of evidence supporting coffee’s liver-protective effects. Their FAQs state that drinking coffee is likely to be good for your liver, and may even slow down the progress of liver disease in some people. They suggest that consuming three to four cups daily may be beneficial, but emphasize that coffee should not be considered a standalone solution and should be combined with a healthy diet, regular exercise, and reduced alcohol consumption.

A study published by the American Institute for Cancer Research on June 22, 2021, further reinforces the link between coffee consumption and reduced liver disease risk, regardless of whether the coffee is caffeinated or decaffeinated. Cleveland Clinic Health Essentials, in an article published on January 29, 2025, states that drinking coffee may be good for the liver by decreasing inflammation and helping remove damaged cells.

The National Institutes of Health (NIH) also published research on the topic in February 2016, confirming the clinical evidence of benefit of coffee consumption in Hepatitis B and C, as well as nonalcoholic fatty liver disease and alcoholic liver disease.